companydata.dkcompanydata.dk

Optoceutics ApS: Financial statements 2025

CVR: 39769689

Source: annual report 2025, Danish Business Authority

01/01/202531/12/2025

Optoceutics ApS (CVR 39769689) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -2,585,556 and a net result of DKK -8,736,152 compared with DKK -9,184,625 the year before. Equity in the 2025 report amounted to DKK 32,320,160. The solvency ratio was 74.2%. The company had 7 employees in the financial year.

Gross Profit
DKK -2,585,556
Profit/Loss
DKK -8,736,152
Equity
DKK 32,320,160
Total Assets
DKK 43,577,521
Employees
7

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--2.6 mio.-8.7 mio.32.3 mio.7
2024--519 t.-9.2 mio.34.1 mio.11
2023-910 t.-7.2 mio.28.9 mio.14
2022-4.3 mio.-3.6 mio.16.9 mio.14
2021--2.2 mio.-3.9 mio.13.4 mio.10

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Optoceutics ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Optoceutics ApS: The 2024 annual report is outJun 26, 2025

Optoceutics ApS has published its annual report for 2024. Gross profit came to DKK -519,340, and the net result was DKK -9,184,625.

Jes Broeng joins the board of Optoceutics ApSMay 20, 2025

As of May 20, 2025, Jes Broeng has joined the board of directors of Optoceutics ApS.

Jes Broeng leaves the board of Optoceutics ApSMay 19, 2025

As of May 19, 2025, Jes Broeng has left the board of directors of Optoceutics ApS.

David Lee Hardwick leaves the board of Optoceutics ApSMay 13, 2025

As of May 13, 2025, David Lee Hardwick has left the board of directors of Optoceutics ApS.

About Optoceutics ApS

Optoceutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Optoceutics IVS. The management consists of Ngoc Mai Thi Nguyen and Marcus Schultz Carstensen. The board consists of Jes Broeng (chair), Kaare Agerholm Danielsen, Marcus Schultz Carstensen and Ngoc Mai Thi Nguyen. The company's owners include Vjack Holding ApS, M. S. C. HOLDING ApS and Danielsen 2 ApS. According to the 2025 annual report, the company had an average of 7 employees. In 2025, the company reported a gross profit of DKK -2,585,556 and a net result of DKK -8,736,152 compared with DKK -9,184,625 the year before. Equity in the 2025 report amounted to DKK 32,320,160.

Source: annual report 2025, Danish Business Authority

Other financial years